I advise hospitals, health ministries, and laboratories on antimicrobial resistance, antimicrobial stewardship, infection control, and molecular diagnostics — translating rigorous research into policy institutions can actually implement. With over three decades in clinical and molecular microbiology, 60+ peer-reviewed publications, and national biosecurity experience, I help organisations design stewardship programmes, strengthen laboratory quality, and respond to outbreaks.
My work in this area is grounded in active research and clinical laboratory leadership. I have published on carbapenem resistance, ESBLs, the genomic surveillance of SARS-CoV-2 variants in the Middle East, and the evidence base for national and regional policy interventions against resistance, including work in The Lancet. This combination of bench-level molecular expertise and policy-level perspective is what allows advisory work to move from diagnosis to durable solutions.
Setting Up an Antimicrobial Stewardship Programme: A Hospital's First 90 Days →
AMR in the Gulf: What Health Ministries Should Prioritise →
PCR vs Sequencing: Choosing Molecular Diagnostics for a Clinical Microbiology Lab →
A stewardship programme combines governance (a multidisciplinary team and clear mandate), interventions (formulary control, prospective audit and feedback, prescribing guidelines), surveillance of antimicrobial use and resistance, and education. I help institutions design the programme, sequence its rollout, and build the measurement that proves it works.
Infection control focuses on preventing transmission; antimicrobial stewardship focuses on preserving the drugs themselves by ensuring appropriate use. The two are complementary, and effective AMR strategy usually needs both, supported by molecular diagnostics and surveillance.
Yes. Advisory covers PCR and sequencing-based diagnostics, genomic profiling of resistant organisms, and building AMR surveillance strategy — grounded in hands-on research experience including variant analysis and carbapenem-resistance characterisation.
Yes. Engagements range from single-hospital stewardship design to national and regional AMR surveillance strategy for ministries and international bodies, with particular experience in the Gulf and Middle East.
I would be glad to discuss how my expertise can support that work.
Start a Conversation